DermBiont, Inc.

Quick facts

Phase 2 pipeline

• DBI-001 Gel
• DBI-002 Gel · Dermatology
  DBI-002 Gel is a topical treatment that modulates the skin microbiome to improve symptoms of atopic dermatitis.
• DBI-002 probiotic gel
• DBI-102
• Janthinobacterium lividum
• SM-020
• SM-020 1% Gel
• SM-020 gel 1.0%
• SM-030 gel 0.08%
• SM-030 gel 0.64%

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• DermBiont, Inc. portfolio CI brief
• DermBiont, Inc. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies